Focused On Life

Developing novel therapies for serious diseases

Learn More
Focused On Life Developing novel therapies for serious diseases
Driven By Science Rapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Medivation is proud to be a 2013 Top Workplace Learn More
Top Workplaces 2013 Bay Area News Group
Latest News

April 3, 2014
Astellas Announces European Regulatory Submission For XTANDI® (enzalutamide) Capsules For Chemotherapy-Naive Metastatic Prostate Cancer Learn More